February 13, 2023
China’s Balloon-Size Blunder Is a Huge Opportunity
In the pre-balloon era, China was busily engaged in a charm offensive. Following October’s Communist Party congress, at which Xi Jinping won an unprecedented third term in office, Beijing made moves to stifle the combative and confrontational group of diplomats known as wolf warriors. Xi hosted German Chancellor Olaf Scholz in the capital, and condemned Russia’s threats to use nuclear weapons in Ukraine. The tone of China’s leading diplomats noticeably softened. Vice Premier Liu He, meeting with corporate executives in Davos, Switzerland, emphasized that China was back and open for business. And for the first time in almost six years, Xi planned to host a U.S. secretary of state in China.
Whether a product of hubris or incompetence, the Chinese-spy-balloon affair has derailed Beijing’s charm offensive and raised grave suspicions among Americans.
Then a Chinese spy balloon drifted across the U.S., and into America’s consciousness. The very brazenness of the act upended Beijing’s carefully tended diplomatic campaign and forced it into damage-control mode. At the same time, the balloon handed the United States, already engaged in heightened competition with China, a rare opportunity to rally both public concern and international solidarity.
Read the full article from The Atlantic.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
